“…Regarding US data, where approximately 60% of the studied population were using insulin pump, considered to be the gold standard therapy for T1D, the control rate was 17-23% in patients younger than 18 years old, 14% in subjects aged 18 -25 years old, and about 30% among adults over 25 years old, with a mean HbA1c of 8.2-9.0%, 8.7% and 7.6-7.7%, respectively [20]. In our study, only 22.14% of the patients (21.74% individuals ≤ 18 years old and 22.53% adults > 18 years old) reached the recommended goal, which is in agreement with that reported in the literature [5,10,20,21]. A greater number of consultations per year also did not imply in a better glycemic control.…”